151 related articles for article (PubMed ID: 17387143)
1. The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression.
Baran AA; Silverman KA; Zeskand J; Koratkar R; Palmer A; McCullen K; Curran WJ; Edmonston TB; Siracusa LD; Buchberg AM
Genome Res; 2007 May; 17(5):566-76. PubMed ID: 17387143
[TBL] [Abstract][Full Text] [Related]
2. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.
Silverman KA; Koratkar R; Siracusa LD; Buchberg AM
Genome Res; 2002 Jan; 12(1):88-97. PubMed ID: 11779834
[TBL] [Abstract][Full Text] [Related]
3. Exclusion of Madh2, Madh4, and Madh7 as candidates for the modifier of Min 2 (Mom2) locus.
Silverman KA; Koratkar RA; Siracusa LD; Buchberg AM
Mamm Genome; 2003 Feb; 14(2):119-29. PubMed ID: 12584607
[TBL] [Abstract][Full Text] [Related]
4. Analysis of reciprocal congenic lines reveals the C3H/HeJ genome to be highly resistant to ApcMin intestinal tumorigenesis.
Koratkar R; Silverman KA; Pequignot E; Hauck WW; Buchberg AM; Siracusa LD
Genomics; 2004 Nov; 84(5):844-52. PubMed ID: 15475263
[TBL] [Abstract][Full Text] [Related]
5. Identification of Mom7, a novel modifier of Apc(Min/+) on mouse chromosome 18.
Kwong LN; Shedlovsky A; Biehl BS; Clipson L; Pasch CA; Dove WF
Genetics; 2007 Jun; 176(2):1237-44. PubMed ID: 17435219
[TBL] [Abstract][Full Text] [Related]
6. The CAST/Ei strain confers significant protection against Apc(Min) intestinal polyps, independent of the resistant modifier of Min 1 (Mom1) locus.
Koratkar R; Pequignot E; Hauck WW; Siracusa LD
Cancer Res; 2002 Oct; 62(19):5413-7. PubMed ID: 12359746
[TBL] [Abstract][Full Text] [Related]
7. Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesis.
Crist RC; Roth JJ; Lisanti MP; Siracusa LD; Buchberg AM
Cell Cycle; 2011 Apr; 10(7):1092-9. PubMed ID: 21386660
[TBL] [Abstract][Full Text] [Related]
8. Genetic basis of variation in adenoma multiplicity in ApcMin/+ Mom1S mice.
Haines J; Johnson V; Pack K; Suraweera N; Slijepcevic P; Cabuy E; Coster M; Ilyas M; Wilding J; Sieber O; Bodmer W; Tomlinson I; Silver A
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2868-73. PubMed ID: 15710876
[TBL] [Abstract][Full Text] [Related]
9. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
[TBL] [Abstract][Full Text] [Related]
10. Genetic mapping of Mom5, a novel modifier of Apc(Min)-induced intestinal tumorigenesis.
Oikarinen SI; Cleveland AG; Cork KM; Bynoté KK; Rafter JJ; Gustafsson JA; Mutanen M; Gould KA
Carcinogenesis; 2009 Sep; 30(9):1591-6. PubMed ID: 19574546
[TBL] [Abstract][Full Text] [Related]
11. Exclusion of an extracolonic disease modifier locus on chromosome 1p33-36 in a large Swiss familial adenomatous polyposis kindred.
Plasilova M; Russell AM; Wanner A; Wolf A; Dobbie Z; Müller HJ; Heinimann K
Eur J Hum Genet; 2004 May; 12(5):365-71. PubMed ID: 14735163
[TBL] [Abstract][Full Text] [Related]
12. Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse Smad4 gene.
Hohenstein P; Molenaar L; Elsinga J; Morreau H; van der Klift H; Struijk A; Jagmohan-Changur S; Smits R; van Kranen H; van Ommen GJ; Cornelisse C; Devilee P; Fodde R
Genes Chromosomes Cancer; 2003 Mar; 36(3):273-82. PubMed ID: 12557227
[TBL] [Abstract][Full Text] [Related]
13. The ROSA26 LacZ-neo(R) insertion confers resistance to mammary tumors in Apc(Min/+) mice.
Kohlhepp RL; Hegge LF; Moser AR
Mamm Genome; 2001 Aug; 12(8):606-11. PubMed ID: 11471054
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel modifier loci of Apc Min affecting mammary tumor development.
Wang H; Teske D; Tess A; Kohlhepp R; Choi Y; Kendziorski C; Moser AR
Cancer Res; 2007 Dec; 67(23):11226-33. PubMed ID: 18056448
[TBL] [Abstract][Full Text] [Related]
15. The putative tumour modifier gene ATP5A1 is not mutated in human colorectal cancer cell lines but expression levels correlate with TP53 mutations and chromosomal instability.
Seth R; Keeley J; Abu-Ali G; Crook S; Jackson D; Ilyas M
J Clin Pathol; 2009 Jul; 62(7):598-603. PubMed ID: 19261598
[TBL] [Abstract][Full Text] [Related]
16. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.
MacPhee M; Chepenik KP; Liddell RA; Nelson KK; Siracusa LD; Buchberg AM
Cell; 1995 Jun; 81(6):957-66. PubMed ID: 7781071
[TBL] [Abstract][Full Text] [Related]
17. Lack of guanylyl cyclase C, the receptor for Escherichia coli heat-stable enterotoxin, results in reduced polyp formation and increased apoptosis in the multiple intestinal neoplasia (Min) mouse model.
Mann EA; Steinbrecher KA; Stroup C; Witte DP; Cohen MB; Giannella RA
Int J Cancer; 2005 Sep; 116(4):500-5. PubMed ID: 15825168
[TBL] [Abstract][Full Text] [Related]
18. DRO1 inactivation drives colorectal carcinogenesis in ApcMin/+ mice.
Grill JI; Neumann J; Herbst A; Hiltwein F; Ofner A; Marschall MK; Wolf E; Kirchner T; Göke B; Schneider MR; Kolligs FT
Mol Cancer Res; 2014 Nov; 12(11):1655-62. PubMed ID: 25053805
[TBL] [Abstract][Full Text] [Related]
19. No effects of Smad2 (madh2) null mutation on malignant progression of intestinal polyps in Apc(delta716) knockout mice.
Takaku K; Wrana JL; Robertson EJ; Taketo MM
Cancer Res; 2002 Aug; 62(16):4558-61. PubMed ID: 12183405
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice.
Liu HP; Gao ZH; Cui SX; Wang Y; Li BY; Lou HX; Qu XJ
Int J Cancer; 2013 Jun; 132(11):2667-81. PubMed ID: 23132636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]